MCRB Seres Therapeutics Inc
Market Cap
681.52M
Dayโs Range
52W Range
Volume (3M)
760.35K
Price-Earnings Ratio
-
Revenue
13.37M
Seres Therapeutics Inc Latest News



Top Discussions
28
FEB
REPORTS
Seres Therapeutics Inc Q4 2022 earnings report is expected to be released before market open

MCRB
Seres Therapeutics Inc
5.47
0.01
(0.18%)

MCRB
Seres Therapeutics Inc
5.46
0.01 (0.18%)
2
NOV
REPORTS
Seres Therapeutics Inc Q3 2022 earnings report released before market open

MCRB
Seres Therapeutics Inc
5.47
0.01
(0.18%)

MCRB
Seres Therapeutics Inc
5.46
0.01 (0.18%)
About Seres Therapeutics Inc
Operating internationally, the healthcare firm Seres Therapeutics works to develop biological drugs. The company seeks to revolutionise the treatment for a range of diseases through human microbiome modulation. Founded in 2010, Seres Therapeutics has headquarters in Cambridge, Massachusetts. Listed under the MCRB ticker, the company's stock is available on the NASDAQ GS stock market. Find the best time to buy MCRB stock by following it with your eToro watchlist.
Show More333
Employees
Cambridge, Massachusetts, US
HQ
2010
Founded
Eric D. Shaff, MBA
CEO
Upcoming Earnings
28
FEB
REPORTS
Seres Therapeutics Inc Q4 2022 earnings report is expected to be released before market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
46
Low
Industry
Avg. 45
32
Environment
41
Social
55
Governance
People Also Bought
- AXGN Axogen Inc. -2.67%
- PRG Prog Holdings Inc 2.96%
- CLDX Celldex Therapeutics Inc -0.23%
- INFN Infinera Corp 3.54%
IHS IHS Holding 1.72%
CTKB Cytek Biosciences Inc 2.90%
- ALKS Alkermes plc -0.52%
IRWD Ironwood Pharmaceuticals Inc. 2.86%